Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP161541.RAk-uG3rJGbwwtQR6CI0p6RstSmTcgu5BjMUm1YPHf_58130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP161541.RAk-uG3rJGbwwtQR6CI0p6RstSmTcgu5BjMUm1YPHf_58130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP161541.RAk-uG3rJGbwwtQR6CI0p6RstSmTcgu5BjMUm1YPHf_58130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP161541.RAk-uG3rJGbwwtQR6CI0p6RstSmTcgu5BjMUm1YPHf_58130_provenance.
- NP161541.RAk-uG3rJGbwwtQR6CI0p6RstSmTcgu5BjMUm1YPHf_58130_assertion wasGeneratedBy ECO_0000203 NP161541.RAk-uG3rJGbwwtQR6CI0p6RstSmTcgu5BjMUm1YPHf_58130_provenance.
- NP161541.RAk-uG3rJGbwwtQR6CI0p6RstSmTcgu5BjMUm1YPHf_58130_assertion wasDerivedFrom befree-20140225 NP161541.RAk-uG3rJGbwwtQR6CI0p6RstSmTcgu5BjMUm1YPHf_58130_provenance.
- NP161541.RAk-uG3rJGbwwtQR6CI0p6RstSmTcgu5BjMUm1YPHf_58130_assertion SIO_000772 19361262 NP161541.RAk-uG3rJGbwwtQR6CI0p6RstSmTcgu5BjMUm1YPHf_58130_provenance.
- NP161541.RAk-uG3rJGbwwtQR6CI0p6RstSmTcgu5BjMUm1YPHf_58130_assertion evidence source_evidence_literature NP161541.RAk-uG3rJGbwwtQR6CI0p6RstSmTcgu5BjMUm1YPHf_58130_provenance.
- NP161541.RAk-uG3rJGbwwtQR6CI0p6RstSmTcgu5BjMUm1YPHf_58130_assertion description "[Furthermore, in vivo administration of GM-CSF at 60 microg/kg body weight daily for 5 consecutive days beginning immediately after injury decreased infarction volume, altered the expression of several apoptosis-related genes (Bcl-2, Bax, caspase 3, and p53), and improved locomotor behavior in the focal cerebral ischemia model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP161541.RAk-uG3rJGbwwtQR6CI0p6RstSmTcgu5BjMUm1YPHf_58130_provenance.
- befree-20140225 importedOn "2014-02-25" NP161541.RAk-uG3rJGbwwtQR6CI0p6RstSmTcgu5BjMUm1YPHf_58130_provenance.